SCHEMBL19106286

SCHEMBL19106286

c1ccc(-c2ccc(-c3cc(-c4ccc(-c5ccccc5)cc4)nc(-c4ccc5cc6cc(-c7nc(-c8ccccc8)c8sc9ccccc9c8n7)ccc6cc5c4)n3)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 1/20 0.37
▸ CYP1B1 Q16678 1/20 0.37
▸ MEN1 O00255 5/20 0.37
▸ KMT2A Q03164 5/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ MAPT P10636 3/20 0.37
▸ HPGD P15428 3/20 0.37
▸ NTSR1 P30989 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ TNKS O95271 3/20 0.35
▸ TNKS2 Q9H2K2 3/20 0.35
▸ LIMK1 P53667 2/20 0.34
▸ MAOA P21397 1/20 0.33
▸ MAOB P27338 1/20 0.33
▸ PIM1 P11309 1/20 0.33
▸ PIM3 Q86V86 1/20 0.33
▸ PIM2 Q9P1W9 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ GLA P06280 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19106283 0.96 CYP1A1 (0.40) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL19106308 0.90 MEN1 (0.45) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL19106211 0.90 MEN1 (0.45) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL18158349 0.89 MEN1 (0.42) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL16902377 0.89 ADORA2A (0.39) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL19106361 0.88 MEN1 (0.37) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL18158337 0.88 MEN1 (0.41) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL19106365 0.88 MEN1 (0.37) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL18158367 0.88 MEN1 (0.41) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL18158335 0.88 MEN1 (0.41) MEN1KMT2AALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same DUK SAN NEOLUX CO., LTD (KR) 2020-08-04 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME NFE2L2, ESR1, VDAC2 CYP1A1 1209/4885CYP1B1 2433/4885MEN1 1003/4885
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same NFE2L2, ESR1, VDAC2 CYP1A1 1209/4885CYP1B1 2433/4885MEN1 1003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback